This early-phase study is testing whether adding an investigational drug called azeliragon to the standard initial treatment (radiation plus temozolomide chemotherapy) is safe for adults newly diagnosed with glioblastoma, an aggressive brain cancer. The main goal is to find a saf…
Phase: PHASE1, PHASE2 • Sponsor: Cantex Pharmaceuticals • Aim: Disease control
Last updated Apr 02, 2026 05:57 UTC